IAVI 009
Status:Completed
Phase:I
Principal Investigator(s):
Objective:Test the safety and immunogenicity of a clade A HIV-DNA/MVA prime-boost combination, in HIV-uninfected healthy volunteers at low risk for HIV infection. In addition, the effect of priming with DNA once or twice prior to MVA boost will be determined.
Prevention Option(s):HIV Vaccine
Study Design:Controlled, Double-blind, Placebo, Randomized
Arms and Assigned Interventions
DescriptionHIV-DNA/MVA prime-boost & priming with DNA once or twice prior to MVA boost
Mode of Delivery
ARMsExperimental
Official Code:
IAVI 009
Trial Sponsors:
Uganda Virus Research Institute-International AIDS Vaccine Initiative (UVRI-IAVI)
Start Date
End Date
none
none
Enrollment:50
Age range:
↔
any
Population:Cisgender Men, Cisgender Women